User talk:Ref_Desk_Ron

Welcome to PeptidePedia Wiki. Two things worth reading early: Project:Verifiability, which is stricter here than on most wikis because of the subject matter, and Project:Manual of style, which settles the unit and spelling conventions so that articles can be read comparatively.

If a claim is worth making it is worth citing, and if a number is worth giving it is worth giving with its units and its source. Ask anything on the talk page of the article in question — that is where the reference-desk traffic goes. — BlankVialBo (talk) 03:05, 11 August 2024 (UTC)

★ Awarded for the work on Oral semaglutide and GenScript Peptides. Both were among the most-linked unwritten titles on the wiki and both are now genuinely useful. Sourcing every non-obvious sentence in a pair of articles that size is a long piece of work and it does not show. — ExenatideEzra (talk) 14:21, 1 September 2025 (UTC)

Much appreciated. Sourcing every non-obvious sentence took longer than writing them, which is the part that does not show. — Ref_Desk_Ron (talk) 15:17, 2 September 2025 (UTC)

Your recent edits to SinoPep have consistently favoured one organisation, and one of them added promotional wording. If you have a professional relationship with the subject, Project:Conflict of interest requires you to disclose it and to propose changes on the talk page rather than making them directly. If you do not, then this is simply a note that the wording was reading as promotional. — UnitsUrsula (talk) 20:56, 20 September 2025 (UTC)

I have no connection with the subject. I have rewritten the paragraph to attribute every evaluative statement in it. — Ref_Desk_Ron (talk) 23:05, 21 September 2025 (UTC)

Given your edits around Trial data comparison, you might find the working-group pages useful — Project:Analytical working group, Project:Pharmacology working group and Project:Clinical evidence working group each keep a short priority list, and the priorities are mostly things one person can finish in an afternoon. — DiffWatchDov (talk) 04:25, 14 November 2025 (UTC)

Thank you for the invitation. I have watchlisted all three and joined the one nearest my reading. — Ref_Desk_Ron (talk) 11:41, 14 November 2025 (UTC)

In Satiety signalling you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — HalfLifeHavel (talk) 17:33, 16 March 2026 (UTC)

Fair. The comparator was in the same table and I had simply not carried it across. — Ref_Desk_Ron (talk) 08:59, 17 March 2026 (UTC)

The filter control on Peptide stability table changes state without announcing it, so a reader using a screen reader gets no confirmation that anything happened. A label tied to the control would fix it. I have not edited the page because the interactive parts are yours. — ThymosinTamsin (talk) 03:04, 21 April 2026 (UTC)

Thank you — fixed. The state is now announced and the control has a proper label. — Ref_Desk_Ron (talk) 11:52, 21 April 2026 (UTC)

An automated pass normalised the citation formatting on Satiety signalling and expanded two bare identifiers into full citations. One reference could not be resolved and has been left tagged. This is an automated message; replies to it are read by a human eventually, but the article talk page is faster. — StubSorterBot (talk) 18:58, 16 May 2026 (UTC)